

HY-168013 · 50 mg
MedChemExpress · Cat: HY-168013
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/krasg12c-in-14.htmlDescription
KRASG12C IN-14 compound 15 is an inhibitor targeting the KRAS G12C mutation. KRASG12C IN-14 inhibits CYPA-dependent KRAS-BRAF with an IC50 of 0.002 ?M. KRASG12C IN-14 inhibits ERK phosphorylation in NCI-H358 cells with an IC50 of 0.002 ?M.







